Table 1.

Recent preclinical studies of human tumours treated with miRNA.

Cancer	microRNA	Delivery	Dispensing Route	Reference
Breast carcinoma	miR-10b	2′-O-Me-modified	Tail vein	54
	duplex miR-22	RNA-jetPEI (polyethylenimine)	Local	55
Non-small cell lung cancer	Pre-miR-34a	Lipid-based delivery vehicle	Local and systemic	47
	Pre-miR-let7b	Lipid-based delivery vehicle	Local and systemic	52,53
Lung cancer	Pre-miR-133b	cationic lipoplexes	Systemic	56
Colon carcinoma	miR-145 and miR-33a	Low molecular weight PEI/miRNA complexes	Local and systemic	57
Prostate tumor	Pre- miR-16	Atelocollagen	Systemic	58
Hepatocarcinoma	miR-143	hsa-miR-143 gene expressing vector	Intratumoral	59